Conclusion
Current COVID-19 pandemic with a need to preserve health care resources and staff can result in cancer care delays and negative impact on patient outcomes. Salivary gland swelling and pain are commonly associated with benign pathology, but the risk of salivary gland malignancy should not be overlooked in the subset of patients with the history and initial evaluation concerning for salivary gland mass. We believe that these patients should undergo additional diagnostic workup to avoid delays in cancer care and negative impact on outcomes. Patient triage, ultrasonographic evaluation and FNAB of salivary gland lesions or, in some cases, immediate contrast-enhanced MRI can help avoid some of the delays. Additional cross-sectional imaging and diagnostic procedures must be postponed if possible. All measures must be taken to minimize COVID-19 exposure.
References
1. Givi B, Schiff BA, Chinn SB, et al. Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic. JAMA Otolaryngol Neck Surg . March 2020.
2. Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzzo RG, Fisher RI. A War on Two Fronts: Cancer Care in the Time of COVID-19. Ann Intern Med . March 2020.
3. Harrison JD. Causes, Natural History, and Incidence of Salivary Stones and Obstructions. Otolaryngol Clin North Am . 2009;42(6):927-947.
4. Lewis AG, Tong T, Maghami E. Diagnosis and Management of Malignant Salivary Gland Tumors of the Parotid Gland. Otolaryngol Clin North Am . 2016;49(2):343-380.
5. Mantravadi AV, Moore MG, Rassekh CH. AHNS series: Do you know your guidelines? Diagnosis and management of salivary gland tumors.Head Neck . 2019;41(2):269-280.
6. Witt RL. Major salivary gland cancer. Surg Oncol Clin N Am . 2004;13(1):113-127.
7. Mossa-Basha M, Meltzer CC, Kim DC, Tuite MJ, Kolli KP, Tan BS. Radiology Department Preparedness for COVID-19: Radiology Scientific Expert Panel. Radiology . March 2020:200988.
8. Pantanowitz L, Thompson LDR, Rossi ED. Diagnostic Approach to Fine Needle Aspirations of Cystic Lesions of the Salivary Gland. Head Neck Pathol . 2018;12(4):548-561.
9. Katz P, Hartl DM, Guerre A. Clinical Ultrasound of the Salivary Glands. Otolaryngol Clin North Am . 2009;42(6):973-1000.
10. Yariv O, Popovtzer A, Wasserzug O, et al. Usefulness of ultrasound and fine needle aspiration cytology of major salivary gland lesions.Am J Otolaryngol . 2020;41(1):102293.
11. Wu S, Liu G, Chen R, Guan Y. Role of ultrasound in the assessment of benignity and malignancy of parotid masses. Dentomaxillofacial Radiol . 2012;41(2):131-135.
12. Rzepakowska A, Osuch-Wójcikiewicz E, Sobol M, Cruz R, Sielska-Badurek E, Niemczyk K. The differential diagnosis of parotid gland tumors with high-resolution ultrasound in otolaryngological practice. Eur Arch Otorhinolaryngol . 2017;274(8):3231-3240.
13. Rossi ED, Faquin WC, Baloch Z, et al. The Milan System for Reporting Salivary Gland Cytopathology: Analysis and suggestions of initial survey. Cancer Cytopathol . 2017;125(10):757-766.
14. Barbarite E, Puram SV, Derakhshan A, Rossi ED, Faquin WC, Varvares MA. A Call for Universal Acceptance of the Milan System for Reporting Salivary Gland Cytopathology. The Laryngoscope . 2020;130(1):80-85.
15. Cytopathology Laboratory Considerations During the COVID-19 Pandemic. College of American Pathologists. https://www.cap.org/laboratory-improvement/news-and-updates/cytopathology-laboratory-considerations-during-the-covid-19-pandemic. Accessed April 8, 2020.
16. Kala C, Kala S, Khan L. Milan System for Reporting Salivary Gland Cytopathology: An Experience with the Implication for Risk of Malignancy. J Cytol . 2019;36(3):160-164.
17. Li Y, Xia L. Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management. Am J Roentgenol . March 2020:1-7.